The effect of new proteasome inhibitors, belactosin A and C, on protein metabolism in isolated rat skeletal muscle

. 2009 Jun ; 65 (2) : 137-46.

Jazyk angličtina Země Španělsko Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid19886392

The proteasome inhibitors are used as research tools to study of the ATP-dependent ubiquitin-proteasome system. Some of them are at present undergoing clinical trials to be used as therapeutic agents for cancer or inflammation. These diseases are often accompanied by muscle wasting. We herein demonstrate findings about new proteasome inhibitors, belactosin A and C, and their direct effect on protein metabolism in rat skeletal muscle. M. soleus (SOL) and m. extensor digitorum longus (EDL) were dissected from both legs of male rats (40-60 g) and incubated in a buffer containing belactosin A or C (30 microM) or no inhibitor. The release of amino acids into the medium was estimated using high performance liquid chromatography to calculate total and myofibrillar proteolysis. Chymotrypsin-like activity (CTLA) of proteasome and cathepsin B, L activity were determined by fluorometric assay. Protein synthesis and leucine oxidation were detected using specific activity of L-[1-14C] leucine added to medium. Inhibited and control muscles from the same rat were compared using paired t-test. The results indicate that after incubation with both belactosin A and C total proteolysis and CTLA of proteasome decreased while cathepsin B, L activity did not change in both SOL and EDL. Leucine oxidation was significantly enhanced in SOL, protein synthesis decreased in EDL. Myofibrillar proteolysis was reduced in both muscles in the presence of belactosin A only. In summary, belactosin A and C affected basic parameters of protein metabolism in rat skeletal muscle. The response was both muscle- and belactosin-type-dependent.

Zobrazit více v PubMed

Endocrinology. 2005 Jul;146(7):3141-9 PubMed

J Biol Chem. 2004 Dec 17;279(51):52914-23 PubMed

J Nutr. 2000 Oct;130(10):2413-9 PubMed

Biochim Biophys Acta. 2004 Nov 29;1695(1-3):189-207 PubMed

Physiol Rev. 2002 Apr;82(2):373-428 PubMed

Nature. 1993 Sep 16;365(6443):264-7 PubMed

J Cell Physiol. 1999 Dec;181(3):455-61 PubMed

J Biol Chem. 1996 Oct 25;271(43):26690-7 PubMed

Annu Rev Immunol. 1999;17:739-79 PubMed

J Anim Sci. 1990 Aug;68(8):2362-70 PubMed

J Biol Chem. 1975 Jan 10;250(1):290-8 PubMed

Anal Biochem. 1980 May 15;104(2):284-9 PubMed

Org Lett. 2007 Apr 12;9(8):1537-40 PubMed

Eur J Clin Invest. 2005 Mar;35(3):157-63 PubMed

J Support Oncol. 2005 May-Jun;3(3):209-17 PubMed

Biochem J. 1977 Mar 15;162(3):557-68 PubMed

Clin Nutr. 2003 Oct;22(5):437-43 PubMed

J Chromatogr B Biomed Sci Appl. 1997 Aug 15;696(1):1-8 PubMed

Am J Physiol. 1999 Oct;277(4):E685-92 PubMed

J Clin Invest. 1996 Mar 15;97(6):1447-53 PubMed

Nature. 1991 Jan 10;349(6305):132-8 PubMed

Chembiochem. 2005 Feb;6(2):222-56 PubMed

Metabolism. 1986 Dec;35(12):1121-7 PubMed

Org Lett. 2004 Jun 24;6(13):2153-6 PubMed

Cancer Lett. 2002 Jun 6;180(1):69-74 PubMed

Nat Rev Mol Cell Biol. 2000 Nov;1(2):145-8 PubMed

J Clin Invest. 1997 Jul 1;100(1):197-203 PubMed

Clin Sci (Lond). 1998 Aug;95(2):225-33 PubMed

Biochem J. 1993 Apr 1;291 ( Pt 1):1-10 PubMed

Am J Physiol. 1998 Jan;274(1):R30-7 PubMed

Biochem Pharmacol. 2004 Jan 15;67(2):227-34 PubMed

Am J Physiol. 1999 Dec;277(6):E1077-86 PubMed

Int J Exp Pathol. 2004 Dec;85(6):365-71 PubMed

Physiol Res. 2005;54(5):541-7 PubMed

Anal Biochem. 1993 Jun;211(2):279-87 PubMed

J Biol Chem. 1951 Nov;193(1):265-75 PubMed

J Nutr. 1999 Jan;129(1S Suppl):227S-237S PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace